Document Detail


Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
MedLine Citation:
PMID:  20500109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To examine and compare the effect of the two commercially available menotropins (highly purified-human menopausal gonadotropin (HP-hMG) and the traditional human menopausal gonadotropin (hMG)) on ovarian stimulation characteristics and in-vitro fertilisation (IVF) cycle outcome.
STUDY DESIGN: We studied 36 patients undergoing at least two controlled ovarian hyperstimulation cycles for IVF, with the same GnRH-analogue protocols, where one included HP-hMG and the other included hMG. Ovarian stimulation characteristics and outcome were compared between the two groups.
RESULTS: Patients in the HP-hMG group achieved significantly higher implantation (20.0% vs. 8.1%, p < 0.03; respectively) and pregnancy rates (47.2% vs. 19.4%, p < 0.009; respectively) compared to the hMG group. Although no in-between group difference was observed in the number of top-quality embryos per patient, the proportion of the total number of top-quality embryos per total number of generated embryos was significantly higher in the HP-hMG group (88/196 vs. 72/204, p < 0.049; respectively) as compared to the hMG group.
CONCLUSIONS: Patients undergoing controlled ovarian hyperstimulation for IVF that includes HP-hMG preparations produce significantly higher implantation and pregnancy rates, as compared to the traditional hMG.
Authors:
Raoul Orvieto; Simion Meltcer; Gad Liberty; Jacob Rabinson; Eyal Y Anteby; Ravit Nahum
Related Documents :
10335469 - In vitro fertilization outcome according to age and follicle-stimulating hormone levels...
571359 - Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinem...
18023439 - Can pregnancy rate be improved in gonadotropin-releasing hormone (gnrh) antagonist cycl...
8866379 - Use of endometrial measurement as an exclusion criterion for in vitro fertilization usi...
2507369 - Methods for monitoring follicle maturation decrease; the ovarian hyperstimulation syndr...
7651639 - The effect of consecutive cycles of clomiphene citrate therapy on endometrial thickness...
2391289 - Common stressors reported by a group of childbearing american women.
16580279 - Calcium supplementation during pregnancy and lactation: effects on the mother and the f...
10456859 - Immunolocalization of progesterone receptors in bovine placentomes throughout mid and l...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  26     ISSN:  1473-0766     ISO Abbreviation:  Gynecol. Endocrinol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  733-5     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, and Ben Gurion University School of Medicine, Beer Sheva, Israel. raoulo@barzi.health.gov.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Fertility Agents, Female / therapeutic use*
Fertilization in Vitro
Humans
Infertility, Female / drug therapy*
Menotropins / standards,  therapeutic use*
Ovulation Induction / methods*
Pregnancy
Pregnancy Rate
Retrospective Studies
Young Adult
Chemical
Reg. No./Substance:
0/Fertility Agents, Female; 61489-71-2/Menotropins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated ...
Next Document:  Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women.